Skip to main content
Premium Trial:

Request an Annual Quote

Amersham Nabs Worldwide Rights to SurModics 3-D Array Slides

NEW YORK, Nov. 19 - Amersham Biosciences' purchase of Motorola's CodeLink business over the summer has also won Amersham exclusive worldwide rights to certain 3-D microarray slides made by SurModics, Amersham said today.

 

Amersham said it intends to market the slides, which have been renamed CodeLink Activated Slides.

 

The slides have a 3-dimensional surface that the company says can enhance the binding of nucleic acid and protein probes during the microarray-creation process.

 

No further information was given.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.